Literature DB >> 16712853

Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease.

S Goya Wannamethee1, Julia Tchernova, Peter Whincup, Gordon D O Lowe, Anne Kelly, Ann Rumley, A Michael Wallace, Naveed Sattar.   

Abstract

BACKGROUND AND AIM: Leptin, an adipocyte-derived protein, regulating food intake and metabolism has been implicated in the development of coronary heart disease. We have examined the relationship between leptin and vascular risk factors including insulin resistance, metabolic, inflammatory and haemostatic risk factors. METHODS AND
RESULTS: The study was carried out in 3640 non-diabetic men aged 60-79 years drawn from general practices in 24 British towns and who were not on warfarin. Leptin was strongly positively correlated with waist circumference (r=0.58; p<0.0001). Leptin concentrations decreased significantly with increasing physical activity and were lowered in cigarette smokers and elevated in men with pre-existing coronary heart disease and stroke; alcohol intake showed no association with leptin concentration. After adjustment for waist circumference and these lifestyle factors, increased leptin was independently associated with significant increases in insulin resistance, triglycerides, inflammatory markers (interleukin-6, C-reactive protein, fibrinogen, plasma viscosity), coagulation factor VIII, endothelial markers von Willebrand factor, tissue plasminogen activator, and fibrin D-dimer levels; and a decrease in HDL-cholesterol. No association was seen between leptin and blood pressure, total cholesterol, glucose or white cell count after adjusting for waist circumference. Further adjustment for insulin resistance abolished the relationships between leptin and triglycerides and HDL-cholesterol, weakened the associations with the haemostatic factors although they remained significant, but made minor differences to the associations with inflammatory markers.
CONCLUSION: Plasma leptin is associated with insulin resistance, inflammation and disturbances in haemostasis independent of waist circumference, suggesting possible pathways by which leptin may influence risk of cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16712853     DOI: 10.1016/j.atherosclerosis.2006.04.012

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  60 in total

1.  Maternal taurine supplementation in the late pregnant rat stimulates postnatal growth and induces obesity and insulin resistance in adult offspring.

Authors:  Karin Hultman; Camilla Alexanderson; Louise Mannerås; Mats Sandberg; Agneta Holmäng; Thomas Jansson
Journal:  J Physiol       Date:  2007-01-04       Impact factor: 5.182

Review 2.  Obesity and inflammation: a new look at an old problem.

Authors:  Sachin Mehta; John A Farmer
Journal:  Curr Atheroscler Rep       Date:  2007-08       Impact factor: 5.113

3.  Clustering of leptin and physical activity with components of metabolic syndrome in Iranian population: an exploratory factor analysis.

Authors:  Alireza Esteghamati; Ali Zandieh; Omid Khalilzadeh; Afsaneh Morteza; Alipasha Meysamie; Manouchehr Nakhjavani; Mohammad Mehdi Gouya
Journal:  Endocrine       Date:  2010-07-11       Impact factor: 3.633

4.  Correlates of leptin in children with chronic kidney disease.

Authors:  Edward Nehus; Susan Furth; Bradley Warady; Mark Mitsnefes
Journal:  J Pediatr       Date:  2014-07-25       Impact factor: 4.406

5.  The role of adipokines as prognostic factors of one-year mortality in hip fracture patients.

Authors:  T Gulin; I Kruljac; L S Kirigin Biloš; M Gulin; M Grgurević; M Borojević
Journal:  Osteoporos Int       Date:  2017-05-13       Impact factor: 4.507

6.  The change of serum leptin and its relationship with platelet membrane glycoprotein Ib in patients with coronary heart disease.

Authors:  Dasheng Xia; Yanqiu Song; Chao Li; Feng Zhang; Minxin Wei
Journal:  Front Med China       Date:  2007-10

7.  Deregulation of adipokines related to target organ damage on resistant hypertension.

Authors:  A R Sabbatini; A P Faria; N R Barbaro; W M Gordo; R G P Modolo; C Pinho; V Fontana; H Moreno
Journal:  J Hum Hypertens       Date:  2013-11-28       Impact factor: 3.012

Review 8.  Role of adipocytokines in predicting the development of diabetes and its late complications.

Authors:  Nese Ersoz Gulcelik; Aydan Usman; Alper Gürlek
Journal:  Endocrine       Date:  2009-09-25       Impact factor: 3.633

9.  Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus.

Authors:  Sema Uslu; Nur Kebapçi; Mehmet Kara; Cengiz Bal
Journal:  Exp Ther Med       Date:  2012-04-23       Impact factor: 2.447

10.  Upregulation of leptin pathway correlates with abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure and reversal by CPU86017.

Authors:  T Na; D Z Dai; X Y Tang; Y Dai
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-02-08       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.